» Articles » PMID: 23803969

Diet-dependent Alterations of Hepatic Scd1 Expression Are Accompanied by Differences in Promoter Methylation

Overview
Journal Horm Metab Res
Specialty Endocrinology
Date 2013 Jun 28
PMID 23803969
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity and alterations of lipid homeostasis are hallmarks of the metabolic syndrome and largely influenced by the dietary conditions of the individual. Although heritability is considered to be a major risk factor, the almost 40 candidate genes identified by genome-wide association studies (GWAS) so far account for only 5-10% of the observed variance in BMI in human subjects. Alternatively, diet-induced changes of epigenetic gene regulation might be involved in disturbed lipid homeostasis and weight development. The aim of this study was to investigate how a high-carbohydrate diet (HCD; 70 kcal% from carbohydrates, 10 kcal% from fat) or a high-fat diet (HFD; 20 kcal% from carbohydrates, 60 kcal% from fat) affects hepatic expression of genes involved in fatty acid metabolism and if these alterations are correlated to changes in promoter methylation. Expression of stearoyl-CoA desaturase 1 (Scd1) was lower in livers from HFD-fed C57BL/6 J mice compared to HCD-fed animals and correlated inversely with the degree of DNA methylation at 2 distinct, adjacent CpG sites in the Scd1 promoter. In contrast, expression of transcription factors peroxisome proliferator activated receptor alpha and gamma (Ppara, Pparg), and sterol regulatory element binding transcription factor 1 (Srebf1) was not affected. The degree of hepatic Scd1 promoter methylation at these CpG sites correlated positively to fat mass and serum leptin levels, whereas serum ghrelin levels were inversely correlated with methylation at both CpG sites. Taken together, hepatic expression of Scd1 is differentially affected by carbohydrate- and lipid content of the diet. These differences in Scd1 expression are associated with altered promoter methylation, indicating that diets affect lipid metabolism in the liver via epigenetic mechanisms.

Citing Articles

Epigenetic Modulation with 5-Aza-CdR Prevents Metabolic-Associated Fatty Liver Disease Promoted by Maternal Overnutrition.

Cheng H, Wu J, Peng H, Li J, Liu Z, Wang X Nutrients. 2025; 17(1.

PMID: 39796540 PMC: 11722594. DOI: 10.3390/nu17010106.


A Moderate Intake of Beer Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a High-Fat Diet (HFD)-Induced Mouse Model.

Vornoli A, Souid A, Lazzari B, Turri F, Pizzi F, Bramanti E Molecules. 2025; 29(24.

PMID: 39770043 PMC: 11676803. DOI: 10.3390/molecules29245954.


Epigenetic Regulation of Obesity-Associated Type 2 Diabetes.

Mohamed Ibrahim H Medicina (Kaunas). 2022; 58(10).

PMID: 36295527 PMC: 9607337. DOI: 10.3390/medicina58101366.


Maternal One-Carbon Supplement Reduced the Risk of Non-Alcoholic Fatty Liver Disease in Male Offspring.

Peng H, Xu H, Wu J, Li J, Wang X, Liu Z Nutrients. 2022; 14(12).

PMID: 35745277 PMC: 9228996. DOI: 10.3390/nu14122545.


Cumulative Metabolic and Epigenetic Effects of Paternal and/or Maternal Supplementation with Arachidonic Acid across Three Consecutive Generations in Mice.

de la Rocha C, Rodriguez-Rios D, Ramirez-Chavez E, Molina-Torres J, Flores-Sierra J, Orozco-Castellanos L Cells. 2022; 11(6).

PMID: 35326508 PMC: 8947399. DOI: 10.3390/cells11061057.